CLLS -3.54% Stock Charts $CLLS Cellectis S.A. ADR

A New Contender in the Battle Over Lab Standards Here's what’s heating up in the realm of clinical laboratories: A proposed shift by the Centers for Medicare & Medicaid Services (CMS) that reeks of cutting corners, if you ask the folks at the Association for Diagnostics & Laboratory Medicine (ADLM). They’re banging the drums against CMS's idea to nix the board...

The Clock is Ticking for AVEX Investors News flash, folks: If you bought into AEVEX Corp. (NYSE: AVEX) between mid-April and early June this year, you might have a legal gold mine on your hands—or at least a shot to join a class action that could knock some dollars back into your pocket. Mark it on your calendar—October 20, 2026, is the last call to toss your hat in...

De¹'s Bold Move into Enhanced Digital Finance Just when you thought the financial landscape couldn’t get any more complex, De¹ steps into the ring with its Tokenized Asset World on the BNB Chain—a move that's stirring the pot of tokenized finance in more ways than one. For old-school investors who thrive on waving outlandish stock bets, this crypto narrative is a...

A New Chapter for Greenwich Kitchens I'll tell you what's catching my eye this time—National Kitchen & Bath Showrooms are making their move into Virginia by snapping up Greenwich Kitchens, a well-regarded name in the local kitchen and bath scene. Founded back in '78, Greenwich Kitchens has been a staple in the Virginia Beach and Hampton Roads areas for nearly half a...

F.N.B. Stays the Course with Strong Q3 2026 Ever heard the phrase “slow and steady wins the race?” That seems to be the mantra over at F.N.B. Corporation (NYSE: FNB) as they roll out their Q3 2026 earnings. Now, they aren't breaking any land speed records, but what they are doing is consistently stepping up their game, quarter by quarter, like clockwork. Drilling Down...

Peter Morrison Steps Up as Chief Growth Officer You know, it's not every day you see a move as gutsy as Nest Health's recent appointment of Peter Morrison. They're shaking up the Medicaid space, aiming to redefine primary care for families with limited resources. Morrison, coming from heavyweights like UnitedHealthcare and Centene, isn't your typical pencil-pusher. He’s...

Coastal Financial Corporation, riding high on NASDAQ as CCB, now finds itself in the middle of a storm. Schall, Brown & Schwartz LLP, a firm known for its shareholder rights litigation, has thrown the gauntlet with a class action lawsuit against Coastal for suspected securities violations. We're talking about potential fibs under Section 10(b) and 20(a) of the Securities...

Endava in Hot Water Over Alleged Misleading Statements Alright, folks, gather around—there's a storm brewing over at Endava with shareholders mightier than the Greek gods, furrowing their brows with intent. You see, Schall, Brown & Schwartz LLP, a firm that practically eats legal challenges for breakfast, is beating the drums of a securities fraud lawsuit. Yep, I'm...

New Era for B2B Sales Teams Once again, the B2B sales landscape is getting a jolt—especially for those who’ve been fumbling in the dark pitching to prospects without any real idea of their tech environment. With the introduction of Firmable's Tech Intelligence, those blind days just got a lot brighter. By offering detailed insights into what technologies a company is...

Cracks in the Facade: QFIN's Legal Mess You're cruising down the usual market lanes when—bam!—news breaks that Qfin Holdings, Inc. (NASDAQ: QFIN) finds itself hip-deep in a class action lawsuit. Seems like our pals at Schall, Brown & Schwartz LLP have thrown the gauntlet down, with claims of some serious smoke and mirrors during the March to August stretch of 2026....

Natural Remedies for Herpes Outbreaks In recent years, there has been an increasing interest in natural remedies to manage herpes outbreaks. As consumer awareness around health continues to evolve, the market for dietary supplements has expanded significantly, reaching a notable $1.23 billion. Amidst this backdrop, Herpafend has emerged as a key player, offering a unique...

Introduction to Pivot Bio's Latest Innovation Pivot Bio is excited to announce the launch of its revolutionary product tailored specifically for cotton growers across the Cotton Belt. The introduction of CERT-N™ marks a significant advancement in agricultural technology, offering farmers an innovative tool to enhance their crop fertility management. About CERT-N™...

Overview of The Bancorp, Inc. Investigation The Bancorp, Inc. (NASDAQ: TBBK) is currently the focus of a significant investigation into potential securities fraud. This probe has raised concerns among investors who may be eligible to recover losses stemming from the company’s financial disclosures. A recent announcement indicates that the corporation's financial...

New Contract Awards by CEMATRIX Corporation CEMATRIX Corporation (TSX: CEMX) (OTCQB: CTXXF) is making headlines with its impressive announcement of securing $5.4 million in fresh contract awards. This notable achievement underscores CEMATRIX's robust reputation as a premier specialty construction contractor that excels in providing innovative cellular concrete solutions...

Investors in Marqeta, Inc. Take Action Investors of Marqeta, Inc. (NASDAQ: MQ) have recently received important news regarding a class action lawsuit that serves as a beacon of hope for those who felt misled while investing in this promising technology company. Understanding the Class Action Lawsuit A class action lawsuit has been initiated against Marqeta, famed for its...